Renaissance Technologies
BPTH

Renaissance Technologies’s Bio-Path Holdings Inc BPTH Stock Holding History

Renaissance Technologies’s Portfolio BPTH Stock Details BPTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,165
Closed -$9K – 4238
2023
Q3 		$9K Buy
1,165
+95
+9% +$1.32K ﹤0.01% 3590
2023
Q2 		$38K Buy
1,070
+55
+5% +$1.7K ﹤0.01% 3666
2023
Q1 		$28K Buy
1,015
+55
+6% +$1.98K ﹤0.01% 3770
2022
Q4 		$29K Buy
960
+30
+3% +$1.31K ﹤0.01% 3896
2022
Q3 		$59K Buy
930
+30
+3% +$2.28K ﹤0.01% 3713
2022
Q2 		$70K Buy
+900
New +$60.8K ﹤0.01% 3932
2021
Q2 		– Sell
-3,690
Closed -$518K – 3864
2021
Q1 		$518K Sell
3,690
-189
-5% -$22.4K ﹤0.01% 2894
2020
Q4 		$272K Buy
3,879
+824
+27% +$61.8K ﹤0.01% 3065
2020
Q3 		$259K Buy
3,055
+830
+37% +$77.7K ﹤0.01% 3046
2020
Q2 		$225K Sell
2,225
-817
-27% -$84.7K ﹤0.01% 3130
2020
Q1 		$274K Buy
+3,042
New +$361K ﹤0.01% 3010
2019
Q4 		– Sell
-2,335
Closed -$444K – 3803
2019
Q3 		$444K Sell
2,335
-3,704
-61% -$919K ﹤0.01% 2910
2019
Q2 		$1.62M Sell
6,039
-2,090
-26% -$663K ﹤0.01% 2444
2019
Q1 		$3.31M Buy
8,129
+6,979
+607% +$1.28M ﹤0.01% 2056
2018
Q4 		$81K Buy
1,150
+596
+108% +$102K ﹤0.01% 3255
2018
Q3 		$131K Buy
554
+57
+11% +$30.8K ﹤0.01% 3217
2018
Q2 		$296K Buy
497
+155
+45% +$108K ﹤0.01% 2968
2018
Q1 		$273K Buy
342
+171
+100% +$133K ﹤0.01% 3106
2017
Q4 		$138K Buy
171
+67
+64% +$86.2K ﹤0.01% 3189
2017
Q3 		$149K Buy
104
+77
+285% +$106K ﹤0.01% 3051
2017
Q2 		$41K Buy
+27
New +$56.6K ﹤0.01% 3133
2016
Q3 		– Sell
-43
Closed -$340K – 3529
2016
Q2 		$340K Buy
43
+14
+48% +$142K ﹤0.01% 2913
2016
Q1 		$302K Buy
29
+9
+45% +$58.3K ﹤0.01% 2979
2015
Q4 		$101K Buy
20
+5
+33% +$29.2K ﹤0.01% 3109
2015
Q3 		$68K Buy
15
+1
+7% +$4.69K ﹤0.01% 3047
2015
Q2 		$63K Buy
+14
New +$76.5K ﹤0.01% 3139

Other funds holding BPTH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SA
Strategic Advocates Logan, Utah $22.6M AUM 26.98% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Renaissance Technologies's BPTH Position: Q4 2023 in Review

Renaissance Technologies sold out of Bio-Path Holdings Inc (BPTH) in Q4 2023, closing a stake of 1,165 shares — an estimated $9K sold.

Renaissance Technologies first reported a position in BPTH in Q2 2015 and held it in 26 quarters. The position peaked at $3.31M in Q1 2019. 19 funds tracked by Wall St. Rank hold BPTH as of Q4 2023.

  • Renaissance Technologies reported no remaining Bio-Path Holdings Inc position as of Q4 2023 after selling out during the quarter.
  • Renaissance Technologies sold 1,165 Bio-Path Holdings Inc shares in Q4 2023, an estimated $9K.
  • Renaissance Technologies first reported a position in Bio-Path Holdings Inc in Q2 2015 and held it in 26 quarters.
  • Renaissance Technologies's Bio-Path Holdings Inc position peaked at $3.31M in Q1 2019.
  • 19 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q4 2023.

Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.